{"entity":{"type":"insider","cik":"0001266773","url":"/insider/0001266773","json_url":"/insider/0001266773.json","name":"CALLICUTT JACK W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":17,"first":"2004-05-11","last":"2026-01-06","span_basis":"filed_date"},"name_variants":[{"name":"CALLICUTT JACK W","source":"filing","n_filings":17,"first_seen":"2004-05-11","last_seen":"2026-01-06"}],"transactions":[{"id":5928884,"accession":"0001133416-26-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001133416-26-000006","line_url":"/filing/0001133416-26-000006#line-4","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20354.0,"shares_display":"20,354","price_per_share":3.6698,"price_display":"3.67","price_state":"stated","total_value":74695.1092,"total_display":"74,695.11","total_whole":"74,695","shares_owned_after":7614.0,"shares_owned_after_display":"7,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-06","scope":"insider"},{"id":5928882,"accession":"0001133416-26-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001133416-26-000006","line_url":"/filing/0001133416-26-000006#line-3","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25732.0,"shares_display":"25,732","price_per_share":3.8978,"price_display":"3.90","price_state":"stated","total_value":100298.1896,"total_display":"100,298.19","total_whole":"100,298","shares_owned_after":27968.0,"shares_owned_after_display":"27,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider"},{"id":5928881,"accession":"0001133416-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001133416-26-000006","line_url":"/filing/0001133416-26-000006#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13914.0,"shares_display":"13,914","price_per_share":4.1968,"price_display":"4.20","price_state":"stated","total_value":58394.2752,"total_display":"58,394.28","total_whole":"58,394","shares_owned_after":53700.0,"shares_owned_after_display":"53,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider"},{"id":4031264,"accession":"0001133416-25-000057","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001133416-25-000057","line_url":"/filing/0001133416-25-000057","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46310.0,"shares_display":"46,310","price_per_share":6.223,"price_display":"6.22","price_state":"stated","total_value":288187.13,"total_display":"288,187.13","total_whole":"288,187","shares_owned_after":7614.0,"shares_owned_after_display":"7,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-19","scope":"insider","n_lines":2},{"id":4031260,"accession":"0001133416-25-000057","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001133416-25-000057","line_url":"/filing/0001133416-25-000057","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31610.0,"shares_display":"31,610","price_per_share":6.0317,"price_display":"6.03","price_state":"stated","total_value":190662.037,"total_display":"190,662.04","total_whole":"190,662","shares_owned_after":7614.0,"shares_owned_after_display":"7,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider","n_lines":3},{"id":4118490,"accession":"0001133416-25-000050","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001133416-25-000050","line_url":"/filing/0001133416-25-000050","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5291.0,"shares_display":"5,291","price_per_share":6.0260154602154605,"price_display":"6.03","price_state":"stated","total_value":31883.6478,"total_display":"31,883.65","total_whole":"31,884","shares_owned_after":7614.0,"shares_owned_after_display":"7,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider","n_lines":3},{"id":4455190,"accession":"0001133416-25-000047","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001133416-25-000047","line_url":"/filing/0001133416-25-000047","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":3600.0,"total_display":"3,600.00","total_whole":"3,600","shares_owned_after":7614.0,"shares_owned_after_display":"7,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-05","filed_date":"2025-11-07","scope":"insider","n_lines":3},{"id":4297115,"accession":"0001133416-25-000043","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001133416-25-000043","line_url":"/filing/0001133416-25-000043","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28629.0,"shares_display":"28,629","price_per_share":6.07,"price_display":"6.07","price_state":"stated","total_value":173778.03,"total_display":"173,778.03","total_whole":"173,778","shares_owned_after":7614.0,"shares_owned_after_display":"7,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-04","filed_date":"2025-11-05","scope":"insider","n_lines":3},{"id":4297083,"accession":"0001133416-25-000043","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001133416-25-000043","line_url":"/filing/0001133416-25-000043","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3810.0,"shares_display":"3,810","price_per_share":6.01,"price_display":"6.01","price_state":"stated","total_value":22898.1,"total_display":"22,898.10","total_whole":"22,898","shares_owned_after":7614.0,"shares_owned_after_display":"7,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-05","scope":"insider","n_lines":3},{"id":4753780,"accession":"0001133416-25-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001133416-25-000039","line_url":"/filing/0001133416-25-000039#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8706.0,"shares_display":"8,706","price_per_share":6.4385,"price_display":"6.44","price_state":"stated","total_value":56053.581,"total_display":"56,053.58","total_whole":"56,054","shares_owned_after":7614.0,"shares_owned_after_display":"7,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-12","filed_date":"2025-09-15","scope":"insider"},{"id":2174035,"accession":"0001133416-24-000068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001133416-24-000068","line_url":"/filing/0001133416-24-000068#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":0.8873,"price_display":"0.89","price_state":"stated","total_value":35492.0,"total_display":"35,492.00","total_whole":"35,492","shares_owned_after":7614.0,"shares_owned_after_display":"7,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-26","scope":"insider"},{"id":6887276,"accession":"0001133416-22-000101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-22-000101","line_url":"/filing/0001133416-22-000101#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.32,"price_display":"1.32","price_state":"stated","total_value":5280.0,"total_display":"5,280.00","total_whole":"5,280","shares_owned_after":7614.0,"shares_owned_after_display":"7,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-17","scope":"insider"},{"id":7954312,"accession":"0001179022-19-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-19-000037","line_url":"/filing/0001179022-19-000037#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2354.0,"shares_display":"2,354","price_per_share":4.28,"price_display":"4.28","price_state":"stated","total_value":10075.12,"total_display":"10,075.12","total_whole":"10,075","shares_owned_after":3614.0,"shares_owned_after_display":"3,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-03","scope":"insider"},{"id":6655228,"accession":"0001179022-18-000056","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179022-18-000056","line_url":"/filing/0001179022-18-000056#line-5","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97267.0,"shares_display":"97,267","price_per_share":8.0812,"price_display":"8.08","price_state":"stated","total_value":786034.0804,"total_display":"786,034.08","total_whole":"786,034","shares_owned_after":1260.0,"shares_owned_after_display":"1,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-20","filed_date":"2018-06-21","scope":"insider"},{"id":6655220,"accession":"0001179022-18-000056","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179022-18-000056","line_url":"/filing/0001179022-18-000056#line-3","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128733.0,"shares_display":"128,733","price_per_share":9.0108,"price_display":"9.01","price_state":"stated","total_value":1159987.3164,"total_display":"1,159,987.32","total_whole":"1,159,987","shares_owned_after":1260.0,"shares_owned_after_display":"1,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-19","filed_date":"2018-06-21","scope":"insider"},{"id":6655207,"accession":"0001179022-18-000052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179022-18-000052","line_url":"/filing/0001179022-18-000052#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9294.0,"shares_display":"9,294","price_per_share":7.0117,"price_display":"7.01","price_state":"stated","total_value":65166.7398,"total_display":"65,166.74","total_whole":"65,167","shares_owned_after":1260.0,"shares_owned_after_display":"1,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-12","filed_date":"2018-06-14","scope":"insider"},{"id":6229768,"accession":"0001179022-18-000048","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179022-18-000048","line_url":"/filing/0001179022-18-000048#line-4","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":6.375,"price_display":"6.38","price_state":"stated","total_value":127500.0,"total_display":"127,500.00","total_whole":"127,500","shares_owned_after":1260.0,"shares_owned_after_display":"1,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-11","filed_date":"2018-06-12","scope":"insider"},{"id":6229762,"accession":"0001179022-18-000048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179022-18-000048","line_url":"/filing/0001179022-18-000048#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":575000.0,"total_display":"575,000.00","total_whole":"575,000","shares_owned_after":1260.0,"shares_owned_after_display":"1,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-12","scope":"insider"},{"id":6311955,"accession":"0001179022-18-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179022-18-000045","line_url":"/filing/0001179022-18-000045#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46651.0,"shares_display":"46,651","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":233255.0,"total_display":"233,255.00","total_whole":"233,255","shares_owned_after":1260.0,"shares_owned_after_display":"1,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-31","filed_date":"2018-06-04","scope":"insider"},{"id":6750038,"accession":"0001179022-18-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179022-18-000025","line_url":"/filing/0001179022-18-000025#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3349.0,"shares_display":"3,349","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":16745.0,"total_display":"16,745.00","total_whole":"16,745","shares_owned_after":1260.0,"shares_owned_after_display":"1,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-04","filed_date":"2018-04-06","scope":"insider"},{"id":6627610,"accession":"0000914062-14-000226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-14-000226","line_url":"/filing/0000914062-14-000226#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.545,"price_display":"4.54","price_state":"stated","total_value":4545.0,"total_display":"4,545.00","total_whole":"4,545","shares_owned_after":1260.0,"shares_owned_after_display":"1,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-14","filed_date":"2014-08-15","scope":"insider"},{"id":4380817,"accession":"0000914062-13-000332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000332","line_url":"/filing/0000914062-13-000332#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":260.0,"shares_display":"260","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":1625.0,"total_display":"1,625.00","total_whole":"1,625","shares_owned_after":260.0,"shares_owned_after_display":"260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-19","filed_date":"2013-11-19","scope":"insider"},{"id":439829,"accession":"0001179022-04-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-04-000122","line_url":"/filing/0001179022-04-000122#line-1","is_derivative":false,"issuer_cik":"0001003929","issuer_name":"CORAUTUS GENETICS INC","issuer_ticker":"CAQ","issuer_name_source":null,"issuer_url":"/issuer/0001003929","owner_cik":"0001266773","owner_name":"CALLICUTT JACK W","owner_display_name":"CALLICUTT JACK W","owner_url":"/insider/0001266773","role":"Officer (VP-Finance&Admin, Chf Acct Off)","role_mark":"O","role_mark_label":"Officer (VP-Finance&Admin, Chf Acct Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Finance&Admin, Chf Acct Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":5500.0,"total_display":"5,500.00","total_whole":"5,500","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-07","filed_date":"2004-05-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001133416","name":"GALECTIN THERAPEUTICS INC","url":"/issuer/0001133416","role":"Officer (Chief Financial Officer)","n_filings":16,"first_seen":"2013-11-19","last_seen":"2026-01-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001003929","name":"CORAUTUS GENETICS INC","url":"/issuer/0001003929","role":"Officer (VP-Finance&Admin, Chf Acct Off)","n_filings":1,"first_seen":"2004-05-11","last_seen":"2004-05-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001266773","retrieved_at":"2026-08-23T15:58:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}